Skip to main content
Figure 1 | Critical Care

Figure 1

From: Neuromuscular blockers and ARDS: Thou shalt not breathe, move, or die!

Figure 1

Forest plot of trials comparing cisatracurium with placebo for 28-day mortality in severe ARDS. Data from studies demonstrate the relative risk (RR) with 95% confidence intervals (CI) for mortality with cisatracurium vs. placebo in patients with ARDS. The RRs < 1 suggest reduced mortality with cisatracurium compared to placebo, whereas RRs >1 suggest increased mortality with cisatracurium. The size of the data markers corresponds to the weight of the studies. Larger markers imply less uncertainty from the results of the individual study and carry more weight in calculating the fixed effects pooled estimate from the systematic review.

Back to article page